Company / Income Tax
Supernus Pharmaceuticals, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$10.5M
FY2025
5-year range
-$10.5M / $24.0M
FY2021-FY2025
Trend
-143.7%
vs FY2024
Sector context
#190 of 204
Health Care
What the data says
Among 204 Health Care companies, Supernus Pharmaceuticals, Inc. is in the top 7% for income tax. Income Tax has fluctuated over the past 10 years, ranging from -$41M in FY2018 to $42M in FY2020.
Based on SEC 10-K filings.
-$10M in FY2025.
Improved from $1M to -$10M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 204This company -$10.5M Sector average $118.7M
▼
-108.8% below sector average
Key checks
Key Insights
- In FY2025, income tax decreased 143.7% year-over-year.
- Ranks #190 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2020.
- Lowest income tax in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.5M | -143.7% |
| FY2024 | $24.0M | +1552.1% |
| FY2023 | $1.5M | +4440.6% |
| FY2022 | $32.0K | -99.8% |
| FY2021 | $19.8M | -52.6% |
| FY2020 | $41.7M | +21.1% |
| FY2019 | $34.4M | +184.3% |
| FY2018 | -$40.9M | -6233.9% |
| FY2017 | $666.0K | +5.7% |
| FY2016 | $630.0K | -5.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026